Medical XpressSecond Prostate-Specific Membrane Antigen PET Scan Can Change Treatment for Nearly Half of Prostate Cancer Patients

ℹ️ Observational Association Only Evidence

PSMA PET imaging plays an increasingly important role in evaluating biochemical recurrence after prostatectomy or radiation therapy. This prospective multicenter registry study examined whether repeating PSMA PET after an initial negative scan identifies clinically meaningful disease and influences treatment planning.

Clinical Considerations

• 210 recurrent prostate cancer patients with an initial negative PSMA PET underwent repeat imaging.
• The second scan detected disease in 56% of patients previously considered imaging-negative.
• Repeat imaging prompted a management change in nearly 50% of patients.
• Positive repeat scans were more likely among patients with higher PSA levels and PSA doubling times under 12 months.

Practice Applications

• Recognize that an initial negative PSMA PET does not exclude recurrent disease.
• Interpret PSA kinetics when determining the potential utility of repeat imaging.
• Consider repeat PSMA PET in selected patients with ongoing biochemical recurrence.
• Monitor evolving evidence regarding imaging-guided management strategies.